HOME
HK STOCK
ALL
Announcement
IPOs
Research
Market
Company
CHINA STOCK
ALL
Announcement
IPOs
Research
Market
Company
US STOCK
ALL
Financial Report
New Share
Market
Research
Company
RECOMMENDATIONS
ALL
World News
Hong Kong & MaCao
China News
General News
HK STOCK
ALL
Announcement
IPOs
Research
Market
Company
CHINA STOCK
ALL
Announcement
IPOs
Research
Market
Company
US STOCK
ALL
Financial Report
New Share
Market
Research
Company
RECOMMENDATIONS
ALL
World News
Hong Kong & MaCao
China News
General News
HOME
HK STOCK
ALL
Announcement
IPOs
Research
Market
Company
CHINA STOCK
ALL
Announcement
IPOs
Research
Market
Company
US STOCK
ALL
Financial Report
New Share
Market
Research
Company
RECOMMENDATIONS
ALL
World News
Hong Kong & MaCao
China News
General News
Search for topics & keywords
Search
On September 7th, CMBC Capital (01141) allocated HKD 157,800 to repurchase 193,000 shares.
07/09/2023
GMT Eight
CMBC CAPITAL (01141) announced that it will repurchase 193,000 shares for HKD 157,800 on September 7, 2023.
Shandong Lukang Pharmaceutical (600789.SH)Nifedipine Extended-release Tablets (I) Passed Generic Drug Consistency Evaluation.
Directors Chen Zhenhua and executives Wu Pengcheng of Harbin VITI Electronics Corp (603023.SH) engaged in insider trading during the window period by buying and selling company stocks.
RECOMMEND
The hottest fund today, the "ultimate answer" to investing?
1 h ago
The other side of the merger and reorganization wave: More than ten listed companies announced termination within the year, with semiconductor companies accounting for over 50%.
1 h ago
Haitong Strategy's 25-year outlook: improvement in both fundaments and A-shares continue their upward trend.
3 h ago
©️2013 - 2024 GMT EIGHT Holdings. All Rights Reserved.
Contact: contact@gmteight.com